The following are the M&A deals, rumors and chatter circulating on Wall Street for Monday July 11, 2016:
Nichi-Iko Pharmaceutical Co. to Acquire Sagent Pharmaceuticals for $21.75/Share in Cash
The Deal:
Nichi-Iko Pharmaceutical Co., Ltd OTC: NHKFF) and Sagent Pharmaceuticals, Inc. SGNT announced Monday, that they have entered into a definitive merger agreement under which Nichi-Iko will acquire Sagent via an all-cash tender offer for $21.75 per share, for a total consideration of approximately $736 million. The acquisition is not subject to any financing condition.
Sagent Pharmaceuticals closed at $21.65 on Monday, up 39.68%.
Concord Medical Announces Takeover Offer for $5.19/Share
The Offer:
Concord Medical Services Holdings Limited CCM announced Monday, that its board of directors has received a non-binding proposal letter, dated July 11, 2016, from Chairman and CEO Jianyu Yang, Morgancreek Investment Holdings Limited and Blue Ocean Management Limited to acquire all of the outstanding Class A ordinary shares and ADSs, each representing three Class A ordinary shares for $1.73 per Class A ordinary share or US$5.19 per ADS. The Board will carefully review the proposal from the buyer to determine the course of action that it believes is in the best interests of the company's shareholders.
Concord Medical closed at $4.29 on Monday, up 10.48%.
UFC Sold for $4B to Group Led by WME-IMG
The Deal:
WME | IMG today announced the acquisition of mixed martial arts promoter Ultimate Fighting Championship or UFC. The purchase price is $ 4 billion.
Shares of WWE moved higher in sympathy, closing Monday at $20.46, up 4.97%.
Xerox in Talks to Merge Copy Business With RR Donnelley
The Rumor:
Xerox Corp XRX.N is said to be in talks to merge its copy business with RR Donnelley, according to a reported as tweeted by CNBC. Xerox closed Monday at $9.50, and traded at $9.80 after-hours.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.